BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17690251)

  • 1. Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs.
    Bhattacharya A; Scott BP; Nasser N; Ao H; Maher MP; Dubin AE; Swanson DM; Shankley NP; Wickenden AD; Chaplan SR
    J Pharmacol Exp Ther; 2007 Nov; 323(2):665-74. PubMed ID: 17690251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.
    Cefalu JS; Guillon MA; Burbach LR; Zhu QM; Hu DQ; Ho MJ; Ford AP; Nunn PA; Cockayne DA
    J Urol; 2009 Aug; 182(2):776-85. PubMed ID: 19539322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitussive activity of iodo-resiniferatoxin in guinea pigs.
    Trevisani M; Milan A; Gatti R; Zanasi A; Harrison S; Fontana G; Morice AH; Geppetti P
    Thorax; 2004 Sep; 59(9):769-72. PubMed ID: 15333853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The research of the possible mechanism and the treatment for capsaicin-induced cough.
    Zhang L; Sun T; Liu L; Wang L
    Pulm Pharmacol Ther; 2018 Apr; 49():1-9. PubMed ID: 29288742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig.
    McLeod RL; Jia Y; Fernandez X; Parra LE; Wang X; Tulshian DB; Kiselgof EJ; Tan Z; Fawzi AB; Smith-Torhan A; Zhang H; Hey JA
    Pharmacology; 2004 Jul; 71(3):143-9. PubMed ID: 15161996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV1 antagonists as potential antitussive agents.
    McLeod RL; Correll CC; Jia Y; Anthes JC
    Lung; 2008; 186 Suppl 1():S59-65. PubMed ID: 17926096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
    Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist.
    Maher MP; Bhattacharya A; Ao H; Swanson N; Wu NT; Freedman J; Kansagara M; Scott B; Li DH; Eckert WA; Liu Y; Sepassi K; Rizzolio M; Fitzgerald A; Liu J; Branstetter BJ; Rech JC; Lebsack AD; Breitenbucher JG; Wickenden AD; Chaplan SR
    Eur J Pharmacol; 2011 Aug; 663(1-3):40-50. PubMed ID: 21575625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-effect of TRPV1 and EP3 receptor on coughs and bronchopulmonary C-neural activities.
    Gao X; Zhuang J; Zhao L; Wei W; Xu F
    PLoS One; 2021; 16(2):e0246375. PubMed ID: 33529249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig.
    Bolser DC; DeGennaro FC; O'Reilly S; Chapman RW; Kreutner W; Egan RW; Hey JA
    Br J Pharmacol; 1994 Dec; 113(4):1344-8. PubMed ID: 7889290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough.
    McLeod RL; Tulshian DB; Ho GD; Fernandez X; Bolser DC; Parra LE; Zimmer JC; Erickson CH; Fawzi AB; Jayappa H; Lehr C; Erskine J; Smith-Torhan A; Zhang H; Hey JA
    Pharmacology; 2009; 84(3):153-61. PubMed ID: 19696521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig.
    Lewis CA; Ambrose C; Banner K; Battram C; Butler K; Giddings J; Mok J; Nasra J; Winny C; Poll C
    Pulm Pharmacol Ther; 2007; 20(4):325-33. PubMed ID: 17240178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
    Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
    Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xingbei antitussive granules ameliorate cough hypersensitivity in post-infectious cough guinea pigs by regulating tryptase/PAR2/TRPV1 pathway.
    Li Y; Zhao R; Zhang M; Shen K; Hou X; Liu B; Li C; Sun B; Xiang M; Lin J
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117243. PubMed ID: 37777025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
    Khalid S; Murdoch R; Newlands A; Smart K; Kelsall A; Holt K; Dockry R; Woodcock A; Smith JA
    J Allergy Clin Immunol; 2014 Jul; 134(1):56-62. PubMed ID: 24666696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat.
    Bolser DC; DeGennaro FC; O'Reilly S; McLeod RL; Hey JA
    Br J Pharmacol; 1997 May; 121(2):165-70. PubMed ID: 9154323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitussive activity of sigma-1 receptor agonists in the guinea-pig.
    Brown C; Fezoui M; Selig WM; Schwartz CE; Ellis JL
    Br J Pharmacol; 2004 Jan; 141(2):233-40. PubMed ID: 14691051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.